Advances in transfusion science for shock-trauma: Optimising the clinical management of acute haemorrhage

2010, Lancet

Hess, 2013, TRASCI

Lavee, 1989, JTCS

Brohi, 2015, Hem-15: developing transfusion based strategies for optimising outcomes following mass casualty events using a discrete event simulation modelling approach, Shock, 44, 5

Rahbar, 2015, Trauma, time, and transfusions: a longitudinal analysis of coagulation markers in severely injured trauma patients receiving modified whole blood or component blood products, Shock, 44, 417, 10.1097/SHK.0000000000000449

2014, Trasci, 51, 105

Salomon, 2015, Clin Lab Inves, 1

Heler, 2015, Use of tranexamic acid in bleeding combat casualties, Mil Med, 180, 844, 10.7205/MILMED-D-14-00592

Brohi, 2015, Hem-11: tranexamic acid is associated with enhanced clot strength, reduced fibrinolysis and reduced acute traumatic coagulopathy in bleeding trauma patients, Shock, 44, 4

D'Alessandro, 2013, Red blood cell metabolism under prolonged anaerobic storage, Mol Biosyst, 9, 1196, 10.1039/c3mb25575a

2014, Free Rad Bio Med

Pallotta, 2014, Storing red blood cells with vitamin C and N-acetylcysteine prevents oxidative stress-related lesions: a metabolomics overview, Blood Transfus, 12, 376

D'Alessandro, 2015, Early hemorrhage triggers metabolic responses that build up during prolonged shock, Am J Physiol

Gould, 2007, Packed red blood cell transfusion in the intensive care unit: limitations and consequences, Am J Crit Care, 16, 39, 10.4037/ajcc2007.16.1.39

Holcomb, 2008, Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients, Ann Surg, 248, 447, 10.1097/SLA.0b013e318185a9ad

Inoba, 2011, Optimal positioning for emergent needle thoracostomy: a cadaver-based study, J Trauma, 71, 1099, 10.1097/TA.0b013e31822d9618

Pati, 2010, Protective effects of fresh frozen plasma on vascular endothelial permeability, coagulation, and resuscitation after hemorrhagic shock are time dependent and diminish between days 0 and 5 after thaw, J Trauma, 69, S55, 10.1097/TA.0b013e3181e453d4

Deng, 2015, Adiponectin in fresh frozen plasma contributes to restoration of vascular barrier function after hemorrhagic shock, Shock

Lovejoy, 2006, Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency, Blood, 108, 57, 10.1182/blood-2005-02-0788

2007, J Am Coll Surg

Sina, 2014, Thrombelastography and rotational thromboelastometry early amplitudes in 182 trauma patients with clinical suspicion of severe injury, J Trauma Acute Care Surg, 76, 682, 10.1097/TA.0000000000000134

Espinoso, 2014, What is happening? The evolving role of the blood bank in the management of the bleeding patient: the impact of TEG as an early diagnostic predictor for bleeding, Transfus Apher Sci, 51, 105, 10.1016/j.transci.2014.10.017

Pidcore, 2012, J Trauma Acute Care Surg

Lopez-Vilchez, 2011, Redistribution and hemostatic action of recombinant activated factor VII associated with platelets, Am J Pathol, 178, 2938, 10.1016/j.ajpath.2011.02.026

Schlimp, 2014, Recovery of fibrinogen concentrate after intraosseous application is equivalent to the intravenous route in a porcine model of hemodilution, J Trauma Acute Surg, 76, 1235, 10.1097/TA.0000000000000174

D'Alessandro, 2012, Time-course investigation of SAGM-stored leukocyte-filtered red blood cell concentrates: from metabolism to proteomics, Hematologica, 97, 107, 10.3324/haematol.2011.051789

Jozwik, 1997, Antioxidant defence of red blood cells and plasma in stored human blood, Clin Chim Acta, 267, 129, 10.1016/S0009-8981(97)00148-4

Pallotta, 2014, Supplementation of anti-oxidants in leucofiltered erythrocyte concentrates: assessment of morphological changes through scanning electron microscopy, Blood Transfus, 12, 421

Seghatchian, 2015, Multilayer-strategy to enhance optimal safety of the blood supply: the role of pathogen inactivation for optimizing recipient safety and helping health care cost containment: moderator views, Transfus Apher Sci, 52, 10.1016/j.transci.2015.02.011

Seghatchian, 2014, Highlights of the role of PMP in health & disease & advancements in PRT and quality in transfusion establishments, Transfus Apher Sci, 52, 10.1016/j.transci.2014.12.014

Espinosa, 2014, The evolving role of the blood bank in the management of the bleeding patient: the impact of TEG as an early diagnostic predictor for bleeding, Transfus Apher Sci, 51, 10.1016/j.transci.2014.10.017

Klausen, 2014, Bacterial contamination of blood components: Norwegian strategies in identifying donors with higher risk of inducing septic transfusion reactions in recipients, Transfus Apher Sci, 51, 10.1016/j.transci.2014.08.007

Hervig, 2014, Storage and handling of blood components – perspectives, Transfus Apher Sci, 51, 10.1016/j.transci.2014.10.001

Burnouf, 2014, Multifaceted regenerative lives of expired platelets in the second decade of the 21st century, Transfus Apher Sci, 51, 10.1016/j.transci.2014.08.006

Seghatchian, 2013, Pathogen inactivation of whole blood and red cell components: an overview of concept, design, developments, criteria of acceptability and storage lesion, Transfus Apher Sci, 49, 10.1016/j.transci.2013.07.023

Seghatchian, 2012, Massive transfusion: an overview of the main characteristics and potential risks associated with substances used for correction of a coagulopathy, Transfus Apher Sci, 47, 235, 10.1016/j.transci.2012.06.001

Seghatchian, 2012, Characteristics of the THERAFLEX UV-Platelets pathogen inactivation system – an update, Transfus Apher Sci, 46, 221, 10.1016/j.transci.2012.01.008

Seghatchian, 2011, Effect of pathogen inactivation on the storage lesion in red cells and platelet concentrates, Transfus Apher Sci, 45, 75, 10.1016/j.transci.2011.06.006

Spinella, 2012, Symposium on fresh whole blood for severe hemorrhagic shock: from in-hospital to far forward resuscitations, Transfus Apher Sci, 46, 113, 10.1016/j.transci.2012.01.002

Seghatchian, 2008, An overview of unresolved inherent problems associated with red cell transfusion and potential use of artificial oxygen carriers and ECO-RBC: current status/future trends, Transfus Apher Sci, 37, 251, 10.1016/j.transci.2007.02.007

Seghatchian, 2007, Current opinions on safer red cell transfusion practice and the appropriate use of alternative strategies, Transfus Apher Sci, 37, 201, 10.1016/j.transci.2007.09.001

Seghatchian, 2006, Platelet storage lesion: the limited impacts of leukoreduction processes in retention of microvesicules, prion, and platelet-derived biological response modifiers, Transfus Apher Sci, 34, 86, 10.1016/j.transci.2005.09.026

Krailadsiri, 2000, Are all leucodepleted platelet concentrates equivalent? Comparison of Cobe LRS Turbo, Haemonetics MCS+ LD, and filtered pooled buffy-coat-derived platelets, Vox Sanguinis, 78, 171, 10.1046/j.1423-0410.2000.7830171.x